Photo: Microscope close up


Fluoxetine is a licensed medication in the treatment of depression. Unfortunately, results from a mid-stage clinical trial called MS-SMART have shown that it is not an effective treatment for MS.

Current phase of trial: Phase 2

Type of MS: Secondary progressive MS

Find out more about fluoxetine